635318-02-4 Usage
Uses
Used in Organic Synthesis:
(1S,3r,5R)-tert-butyl 3-(tert-butoxycarbonyl)-6-oxa-bicyclo[3.1.0]hexane-3-carboxylate is used as a synthetic intermediate for the preparation of complex organic molecules. Its unique structure and functional groups facilitate the formation of new chemical bonds and the synthesis of target compounds with specific properties.
Used in Medicinal Chemistry:
In the pharmaceutical industry, (1S,3r,5R)-tert-butyl 3-(tert-butoxycarbonyl)-6-oxa-bicyclo[3.1.0]hexane-3-carboxylate is used as a building block for the development of novel drug candidates. Its structural features and functional groups can be exploited to design molecules with specific biological activities, potentially leading to the discovery of new therapeutic agents.
Used in Materials Science:
(1S,3r,5R)-tert-butyl 3-(tert-butoxycarbonyl)-6-oxa-bicyclo[3.1.0]hexane-3-carboxylate is used as a component in the development of advanced materials with tailored properties. Its unique molecular structure and functional groups can contribute to the creation of materials with improved performance in various applications, such as polymers, coatings, and adhesives.
Further research and analysis are required to fully explore the potential uses and effects of (1S,3r,5R)-tert-butyl 3-(tert-butoxycarbonyl)-6-oxa-bicyclo[3.1.0]hexane-3-carboxylate in these and other fields. Its distinct molecular architecture and functional groups offer promising avenues for innovation and the development of new applications.
Check Digit Verification of cas no
The CAS Registry Mumber 635318-02-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,5,3,1 and 8 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 635318-02:
(8*6)+(7*3)+(6*5)+(5*3)+(4*1)+(3*8)+(2*0)+(1*2)=144
144 % 10 = 4
So 635318-02-4 is a valid CAS Registry Number.
635318-02-4Relevant articles and documents
Design, development, and scale-up of a selective meso-epoxide desymmetrization process
Varie, David L.,Beck, Christopher,Borders, Sandra K.,Brady, Molly D.,Cronin, Jason S.,Ditsworth, Tracy K.,Hay, David A.,Hoard, David W.,Hoying, Richard C.,Linder, Ryan J.,Miller, Richard D.,Moher, Eric D.,Remacle, Jacob R.,Rieck III, John A.,Anderson, David D.,Dodson, Paul N.,Forst, Mindy B.,Pierson, Duane A.,Turpin, Joseph A.
, p. 546 - 559 (2012/12/31)
A pilot-plant scale desymmetrization of the cyclic meso-epoxide 4b, using a chiral lithium amide prepared from symmetrical diamine 17, was designed and implemented to provide allylic alcohol 3b in high yield and greater than 99% ee. This chiral alcohol was converted to ketone 2b, a key intermediate in a new asymmetric synthesis of LY459477. Chiral diamine 17 was prepared from a readily available chiral precursor, (R)-α-methylbenzylamine, and could be recovered from the reaction mixture and reused. Studies performed to probe the mechanism of the rearrangement reaction of epoxide 4b showed that diamine 17 provided an optimal combination of selectivity and scaleability for this process.
PRODRUGS OF EXCITATORY AMINO ACIDS
-
Page 68-71, (2008/06/13)
This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorder
